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Abstract: Staphylococcus aureus is an opportunistic bacterium causing a wide variety of diseases.
Biofilm formation of Staphylococcus aureus is of primary public and animal health concern. The purposes
of the present study were to investigate the ability of Staphylococcus aureus isolated from animals,
humans, and food samples to form biofilms and to screen for the presence of biofilm-associated and
regulatory genes. In total, 55 Staphylococcus aureus isolated from sheep mastitis cases (n = 28), humans (n
= 19), and from food matrices (n = 8) were identified using matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS). The ability of Staphylococcus aureus for slime
production and biofilm formation was determined quantitatively. A DNA microarray examination
was performed to detect adhesion genes (icaACD and biofilm-associated protein gene (bap)), genes
encoding microbial surface components recognizing adhesive matrix molecules (MSCRAMMs),
regulatory genes (accessory gene regulator (agr) and staphylococcal accessory regulator (sarA)), and
the staphylococcal cassette chromosome mec elements (SCCmec). Out of 55 Staphylococcus aureus
isolates, 39 (71.0%) and 23 (41.8%) were producing slime and biofilm, respectively. All Staphylococcus
aureus strains isolated from food showed biofilm formation ability. 52.6% of the Staphylococcus aureus
strains isolated from sheep with mastitis, and 17.9% of isolates from humans, were able to form a
biofilm. Microarray analysis typed the Staphylococcus aureus into 15 clonal complexes. Among all
Staphylococcus aureus isolates, four of the human isolates (21.1%) harbored the mecA gene (SCCmec
type IV) typed into 2 clonal complexes (CC22-MRSA-IV and CC80-MRSA-IV) and were considered as
methicillin-resistant, while two of them were slime-producing. None of the isolates from sheep with
mastitis harbored the cna gene which is associated with biofilm production. The fnbB gene was found
in 100%, 60% and 40% of biofilm-producing Staphylococcus aureus isolated from food, humans, and
sheep with mastitis, respectively. Three agr groups were present and agr group III was predominant
with 43.6%, followed by agr group I (38.2%), and agr group II (18.2%). This study revealed the capacity
of Staphylococcus aureus isolates to form biofilms and highlighted the genetic background displayed
by Staphylococcus aureus isolates from different sources in Algeria.
Keywords: Staphylococcus aureus; biofilm formation; adhesion genes; microarray assay; Algeria
Pathogens 2020, 9, 153; doi:10.3390/pathogens9020153 www.mdpi.com/journal/pathogens
Pathogens 2020, 9, 153 2 of 15
1. Introduction
Staphylococcus (S.) aureus is a bacterium that can cause a wide range of diseases in humans and
animals. The capacity of S. aureus to colonize and infect different sites of the body is related to
the presence of a variety of virulence factors [1]. Among the virulence factors responsible for the
pathogenicity of S. aureus, adhesion proteins and the ability to form biofilms on biotic and abiotic
surfaces are of importance [2,3]. In human medicine, large numbers of infections are associated with
biofilms produced by staphylococci. The spectrum of clinical presentation comprises osteomyelitis,
endocarditis, and other medical device-related infections such as prosthetic joints, endotracheal tubes,
skeletal prostheses, vascular catheters, cardiac pacemakers, and heart valves [4,5]. Biofilms formed by
S. aureus on food-processing surfaces constitute a critical issue for the food industry and is a dangerous
source of contamination of food matrices and human handlers [6]. Staphylococcus aureus is one of the
most frequent causes of mastitis in dairy cattle and sheep [7–9]. The severity of the disease and the
clinical presentation depends on the production of several toxins and adhesion proteins [10].
Two aspects of biofilm play major roles in the pathogenesis of human and animal infections: first,
the adhesion of the bacteria to epithelial cells thus facilitates the insertion and the release of different
toxins [4,11,12]. Second, decreased diffusion of antimicrobial molecules into the biofilm matrix limits
the effectiveness of antibiotic therapy [13,14]. Moreover, in the food industry, biofilms on surfaces
increase the resistance to disinfectant agents [15].
A biofilm was defined as a structured community of microbial cells embedded in a self-produced
matrix of extracellular polymeric substances, which is attached to a surface [16]. The biofilm-building
process is divided into distinct phases beginning with attachment of staphylococcal cells on a biomaterial,
followed by accumulation and biofilm maturation. The dispersal stage corresponds to the dissemination
of bacterial cells that contaminate other surfaces [15,17]. In staphylococcal biofilms, the attachment
to biotic or abiotic surfaces is facilitated via microbial surface components that recognize adhesive
matrix molecules (MSCRAMMs) and the biofilm-associated protein (Bap) [18]. The accumulation
phase appears to be dependent on polysaccharide intercellular adhesin (PIA) encoded by the icaADBC
operon [17].
The formation of biofilms is a complex process depending on several factors like nutrient
availability, pH value, oxygen level, and surface properties [18]. In addition, biofilm formation in
S. aureus is under the control of two genetic loci, sarA (staphylococcal accessory regulator) and agr
(accessory gene regulator) quorum-sensing system [19,20].
In Algeria, pathogenicity and antimicrobial resistance of staphylococci were investigated in clinical
and food samples [21–23]. However, the biofilm-forming ability of Staphylococcus isolates and their
genetic determinants were rarely evaluated in Algeria [24]. The aim of the present study was to
investigate the phenotypic biofilm formation of S. aureus isolated from different sample types and to
assess the presence of genes that are typically associated with biofilm formation.
2. Materials and Methods
2.1. Bacterial Isolates
Fifty-five S. aureus isolates were chosen from a previous screening study in Algeria [9,21] to assess
their biofilm production ability. The bacterial strains were isolated from food matrices (n = 8), humans
(n = 19; 3 with clinical infections and 16 from nasal carriage), and from cases of mastitis in sheep
(n = 28). Briefly, a total of 112 food samples were taken from several commercial points and local
districts located in Médéa and Ain-defla regions in northern Algeria. Samples were collected from
different matrices. For solid food matrices (minced beef meat, sausages, chicken meat, and creamery
cake) and liquid food matrix (milk), quantities of 100 g and 100 mL were collected in sterile containers
and transferred at 4 ◦C to the laboratory for microbiological examination. The food samples were
processed according to ISO 6888-1/A1 [25] using Baird-Parker medium supplemented with 5% of egg
yolk emulsion (Oxoid Ltd., Basingstoke, UK) and 0.5% potassium tellurite.
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In total, 71 nasal swabs were collected from volunteer persons who had contact with livestock
animals (veterinarians and farmers) to screen the staphylococci nasal carriage. Different clinical
samples (wounds, vaginal discharge, and catheter tips) were collected from hospitalized patients in
the Médéa and Ain-defla regions. The nasal samples were obtained with a sterile cotton swab and the
clinical samples were processed in the same day in the laboratory for microbiology.
In this study, 123 milk samples were aseptically collected from 110 sheep farms in the two
provinces of Médéa and Ain-Defla in northern Algeria. Milk samples were collected from sheep
presenting clinical symptoms of acute mastitis (fever, edema, anorexia with flock abandonment or
suckling refuse, udder pain, consistency or discoloration of udder and bloody secretion). Milk samples
were transported in ice-cooled containers to the microbiology laboratory.
The bacteriological analyses of samples from humans and sheep mastitis cases (nasal swabs, clinical
samples, and milk) were performed according to conventional methods, as described previously [26,27].
Specimens were transferred to Brain Heart Infusion (BHI) broth and incubated overnight at 37 ◦C.
One hundred µL of broth culture were streaked out on Columbia agar (Oxoid Ltd., Basingstoke, UK),
supplemented with 5% sheep blood, and incubated at 37 ◦C for 24 to 48 h. Subsequently, the colonies
were picked and subcultured on Mannitol Salt Agar (MSA) (Oxoid Ltd., Basingstoke, UK). Single
colonies on MSA agar were subjected to Gram staining, catalase, and coagulase tests according to
standard microbiological methods [28].
2.2. Ethics Statement
Study protocol was approved by Medical Ethics Research Committee of the Yahia Farès University,
Urban Pole, Médéa, Algeria, and from the managers of the hospital in which the study was conducted.
Informed written consent was obtained from each participant in the study. Confidentiality and personal
privacy was respected in all levels of the study. Collected data will not be used for any other purpose.
2.3. Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF
MS) Identification
The identification of bacterial species was performed by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS) according to the procedure described
previously [29]. Briefly, a water suspension of cultured bacteria (300 µL) was precipitated with
900 µL of ethanol (96% vol/vol; Carl Roth GmbH, Karlsruhe, Germany) and centrifuged for 5 min at
10,000 × g. The pellet was resuspended in 50 µL of 70% (vol/vol) formic acid (Sigma-Aldrich Chemie
GmbH, Steinheim, Germany), followed by adding 50 µL of acetonitrile (Carl Roth GmbH), mixing,
and centrifugation for 5 min at 10,000 × g. Then, 1.5 µL of the supernatant were spotted onto a MTP
384 Target Plate Polished Steel TF (Bruker Daltonik GmbH, Bremen, Germany) and air-dried. The
dried material was overlaid with 2 µL of a saturated solution of α-cyano-4-hydroxycinnamic acid (in
a solution of 50% acetonitrile, 2.5% trifluoroacetic acid) (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany). Air-drying at room temperature followed. Spectra recording and data analysis were done
with an Ultraflex instrument and Biotyper 3.1 software (Bruker Daltonik GmbH) [30].
2.4. Phenotypic Detection of Slime Production Ability on Congo Red Agar
For testing the ability of slime production, the Congo Red Agar (CRA) assay was used as previously
described [31]. The isolates were inoculated on CRA plates (BHI agar supplemented with 0.8 g/L
Congo Red and 50 g/L of saccharose) and incubated at 37 ◦C for 24 h. The phenotypic identification
of slime-producing colonies was performed according to Arciola et al. [32], where slime-producing
isolates form black colonies and non-producing strains develop red colonies. Colonies of variable
phenotypes (e.g., red colonies with a black center) were considered as slime-producing as described by
Touati et al. [33].
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2.5. Assessment of Biofilm Production by Tissue Culture Plate Assay
The ability of S. aureus isolates to form biofilms was investigated quantitatively by applying a
Tissue Culture Plate (TCP) assay in 96-well microtiter plates as described previously [34]. In brief,
isolated colonies of S. aureus from fresh cultures were inoculated in 5 mL of Trypticase Soy Broth (TSB)
and incubated overnight at 37 ◦C. The cultured suspensions were diluted 1:50 with TSB-1% glucose
medium and 150 µL of the suspension were filled (in triplicates) into wells of a sterile 96-U-bottom
polystyrene plate (PorLab Scientific Co., Ltd, Nanjing, China). TSB-1% glucose served as a negative
control. After 24 h of incubation at 37 ◦C, the content of the wells was gently removed, and washed
with 200 µL of phosphate-buffered saline (PBS; 7 mM Na2HPO4, 3 mM NaH2PO4, and 130 mM NaCl,
pH 7.4). Adherent bacteria were fixed with methanol (p.a.) and stained with 0.1% crystal violet (150
µL/well) for 15 min. Three gentle washing steps followed to remove the excess of stain and the plate
was kept for heat-drying (60 ◦C for 60 min). The fixed crystal violet was solubilized by adding 150 µL
of 96% ethanol, covered, and held without shaking for 30 min. Measurement of the optical density
(OD) was performed at 590 nm using a microtiter plate reader MP96 (Safasmonaco, Monaco, France).
Interpretation of biofilm production was done as described previously [34]. The optical densities of
tested isolates were compared to OD of the negative control (ODc). The biofilm-producing isolates
were categorized into four classes as follows: non-producers (OD < ODc), weak (ODc < OD < 2ODc),
moderate (2ODc < OD < 4ODc), and strong (OD > 4ODc).
2.6. DNA Microarray Analysis
The detection of biofilm-associated genes (icaACD and bap), genes encoding MSCRAMMs (bbp,
clf AB, cna, ebh, ebpS, eno, fib, fnbAB, map, sasG, sdrCD and vwb), and regulatory genes (agrI, II, III, IV
and sarA), as well as SCCmec typing were done using the S. aureus specific DNA microarray assay
(StaphyType; Abbott (Alere Technologies GmbH), Jena, Germany) according to the procedure described
previously [35]. Briefly, purified DNA (after bacterial lysis) was obtained using an automated EZ1
system (Qiagen, Hilden, Germany) according to the protocol supplied by the manufacturer. DNA
samples were subjected to a linear primer elongation using one primer per target. Biotin-16-dUTP was
incorporated into the amplicons. Labeled samples hybridized stringently to the probes of the microarray.
After washing, horseradish-peroxidase-streptavidin conjugation and staining by precipitation of a
dye were performed. The obtained image was analyzed automatically using a reader and software
provided by Abbott (Alere Technologies GmbH). Data interpretation was performed as described
previously [36,37].
2.7. Statistical Analysis
Statistical analysis was performed with StatViewTM software (SAS Institute Inc., Cary, North
Carolina, USA). The differences in the degree of slime production and biofilm formation between
groups were examined by Fisher’s exact test that can be done online at https://www.langsrud.com/stat/
fisher.htm. Results were considered statistically significant at a p value of < 0.05.
3. Results
In total, 55 S. aureus isolates were recovered. Eight S. aureus were isolated from food (1 creamery
cake, 5 raw milk, and 2 minced beef meat), 16 S. aureus isolates were obtained from nasal carriage, 3
from clinical infections of humans, and 28 S. aureus isolates were identified from sheep mastitis cases.
Twenty-three out of 55 S. aureus isolates (41.8%) were found to be biofilm-producing. All food
isolates showed biofilm formation ability. Seven (87.5%) strains were firmly adherent, and one (12.5%)
was moderately adherent. Most S. aureus isolates from sheep mastitis were identified as non-adherent
23 (82.1%), and only 5 (17.9%) of them were biofilm producers. Ten (52.6% ) S. aureus isolates from
humans were adherent (7 isolates were weakly adherent, and 2 were strongly adherent) (Table 1).
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Table 1. Distribution of biofilm and slime-producing S. aureus isolated from sheep, humans, and
food samples.
Criteria Sheep (28)n (%)
Human (19)
n (%)
Food (8)
n (%)
Biofilm-producing
(TCP
performance) *
Positive
Strong 0 2 (10.5) 7 (87.5)
Moderate 2 (7.14) 1 (5.3) 1 (12.5)
Weak 3 (10.7) 7 (36.8) 0
Total 5 (17.9) 10 (52.6) 8 (100)
Negative 23 (82.1) 9 (47.4) 0
Slime-producing
(CRA
performance) **
Slime
Positive 14 (50.0) 9 (47.4) 8 (100)
Variable 4 (14.3) 4 (21.1) 0
Total 18 (64.3) 13 (68.4) 8 (100)
No slime 10 (35.7) 6 (31.6) 0
Biofilm and slime-producing (TCP and CRA) 2 (7.1) 8 (42.1) 8 (100)
* TCP: Tissue Culture Plate; ** CRA: Congo Red Agar
In total, 39 (70.9%) of the isolated S. aureus were found to be slime-producing in the Congo Red
test. All S. aureus isolated from food were slime-producing, whereas 18 (64.3%) and 13 (68.4%) of sheep
and human isolates showed slime production, respectively (Table 1). No significant difference between
animal and human isolates was observed in slime production (p > 0.05).
In a cross-analysis of slime and biofilm production ability with two assays (CRA and TCP), all
food isolates were simultaneously biofilm and slime producers. Only two isolates (7.1%) from sheep
mastitis and 8 (42.1%) from humans were found to be TCP-positive and slime producers.
The results of DNA microarray analysis showed that all isolates from sheep mastitis cases and
food samples were identified as methicillin-sensitive S. aureus (MSSA), while four (21.1%) S. aureus
strains isolated from humans were methicillin-resistant S. aureus (MRSA), harboring the mecA gene
(SCCmec type IV). Among the four MRSA isolates (isolated from nasal swabs), two were weakly
biofilm-producing with slime production, and the others neither showed biofilm production nor
slime production.
Subsequent microarray analysis typed the MSSA into 15 different clonal complexes (CCs) (5 in
sheep, 10 in humans, and 4 in food) (Table 2). The ruminant leukocidin genes lukF-P83 and lukM were
found in 27 (25 sheep, 1 human, and 1 food) isolates belonging to CC130/521, CC479, CC522, and
CC705. Two MSSA isolates (1 from sheep and 1 from human) were not typable. Four MRSA isolated
from humans were typed into 2 CC (CC22-MRSA-IV and CC80-MRSA-IV). The Panton-Valentine
Leukocidin (PVL) gene was detected only in one MRSA isolated from a human.
Isolates were assigned to three agr groups: the predominant agr group was agrIII (43.6%), followed
by agrI (38.2%), and agrII (18.2%). The regulatory gene sarA was detected in all isolates (Tables 3 and 4).
The distributions of biofilm-associated genes, genes encoding MSCRAMMs, and regulatory genes
among isolates regarding biofilm and slime formation are summarized in Tables 3 and 4, respectively.
All isolates harbored icaACD genes but the bap gene was not found.
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Table 2. Genetic diversity of Staphylococcus aureus isolates.
Clonal Complex Sheep (n = 28) Human (n = 19) Food (n = 8) Comments
CC1-MSSA 0 2 (10.5%) 3 (37.5%) Common lineage in cattle and in humans
CC5-MSSA 0 1 (5.3%) 2 (25.0%) Common lineage in humans and in poultry
CC8-MSSA 1 (3.6%) 0 0 Common human lineage, no data on sheep
CC15-MSSA 0 1 (5.3%) 0 Common human lineage
CC22-MSSA 0 4 (21.1%) 0 Common human lineage
CC22-MRSA-IV (tst 1+) 0 3 (15.8%) 0 Common MRSA strain in humans from theMiddle East and the Mediterranean
CC30-MSSA 0 1 (5.3%) 0 Common human lineage
CC45-MSSA 2 (10.5%) Common human lineage
CC80-MRSA-IV (PVL+) 0 1 (5.3%) 0 Common MRSA strain in humans from theMiddle East and the Mediterranean
CC97-MSSA 1 (3.6%) 1 (5.3%) 2 (25.0%) Common lineage in cattle and in humans
CC130/521-MSSA 18 (64.3%) 0 0 Common lineage in sheep/goats
CC398-MSSA 0 1 (5.3%) 0 Common lineage in poultry and increasingly inhumans
CC479-MSSA 2 (11.1%) 0 1 (12.5%) Common lineage in cattle
CC522-MSSA 4 (14.3%) 0 0 Common lineage in sheep/goats
CC705-MSSA 1 (3.6%) 1 (5.3%) 0 Common lineage in cattle, unusual in humans,no sufficient data on sheep
Not identified 1 (3.6%) 1 (5.3%) 0
Total CCs detected 5 10 4
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Table 3. Correlation between biofilm formation ability using TCP assay and distribution of biofilm-associated genes, microbial surface components that recognize
adhesive matrix molecules (MSCRAMMs) genes, and regulatory genes in the tested S. aureus isolates.
Criteria
Sheep Mastitis Isolates (n = 28) Human Isolates (n = 19) Food Isolates (n = 8)
Absence
(23)
Weak
(3)
Moderate
(2)
Strong
(0)
Absence
(9)
Weak
(7)
Moderate
(1)
Strong
(2)
Absence
(0)
Weak
(0)
Moderate
(1)
Strong
(7)
Polysaccharide intercellular
adhesin and biofilm associated
protein genes
icaACD 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
bap 0 0 0 0 0 0 0 0 0 0 0 0
Genes encoding microbial
surface components recognizing
adhesive matrix molecules
(MSCRAMMs)
bbp 23 (100%) 2 (66.6%) 2 (100%) 0 8 (88.8%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 5 (71.4%)
clf A/B 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
cna 6 (26%) 0 0 0 8 (88.8%) 3 (42.8%) 1 (100%) 1 (50%) 0 0 0 4 (57.1%)
ebh 23 (100%) 3 (100%) 2 (100%) 0 5 (55.5%) 4 (57.1%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
ebpS 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
eno 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
fib 23 (100%) 3 (100%) 2 (100%) 0 1 (11.1%) 4 (75.1%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
fnbA 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
fnbB 3 (13.0%) 2 (66.6%) 0 0 4 (44.4%) 3 (42.8%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
map 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
sasG 7 (30.4%) 2 (66.6%) 0 0 5 (55.5%) 6 (85.7%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
sdrC 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
sdrD 15 (65.2%) 2 (66.6%) 2 (100%) 0 7 (77.7%) 6 (85.7%) 1 (100%) 2 (100%) 0 0 1 (100%) 6 (85.7%)
vwb 23 (100%)) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
Regulatory genes
agr
I 5 (21.7%) 2 (66.6%) 0 0 7 (77.7%) 4 (57.1%) 1 (100%) 0 0 0 1 (100%) 1 (14.2%)
II 3 (13.0%) 0 0 0 1 (11.1%) 2 (28.5%) 0 1 (50%) 0 0 0 3 (42.9%)
III 15 (65.2%) 1 (33.3%) 2 (100%) 0 1 (11.1%) 1 (14.2%) 0 1 (50%) 0 0 0 3 (42.9%)
IV 0 0 0 0 0 0 0 0 0 0 0 0
sarA 23 (100%) 3 (100%) 2 (100%) 0 9 (100%) 7 (100%) 1 (100%) 2 (100%) 0 0 1 (100%) 7 (100%)
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Table 4. Correlation between slime production ability using CRA assay and distribution of biofilm-associated genes, MSCRAMMs genes, and regulatory genes in S.
aureus isolates.
Criteria
Sheep Mastitis Isolates (n = 28) Human Isolates (n = 19) Food Isolates (n = 8)
Slime
Producing (18)
No Slime
Producing (10)
Slime
Producing (13)
No Slime
Producing (6)
Slime
Producing (8)
No Slime
Producing (0)
Polysaccharide intercellular adhesin
and biofilm-associated protein genes
icaACD 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
bap 0 0 0 0 0 0
Genes encoding microbial surface
components recognizing adhesive
matrix molecules (MSCRAMMs)
bbp 17 (94.4%) 10 (100%) 12 (92.3%) 6 (100%) 6 (75.0%) 0
clf A/B 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
cna 4 (22.2%) 2 (20.0%) 9 (69.2%) 4 (66.6%) 4 (50.0%) 0
ebh 18 (100%) 10 (100%) 9 (69.2%) 3 (50.0%) 8 (100%) 0
ebpS 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
eno 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
fib 18 (100%) 10 (100%) 6 (46.1%9 2 (33.3%) 8 (100%) 0
fnbA 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
fnbB 18 (100%) 2 (20.0%) 8 (61.5%) 2 (33.3%) 8 (100%) 0
map 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
sasG 6 (33.3%) 3 (30.0%) 10 (76.9%) 4 (66.6%) 8 (100%) 0
sdrC 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
sdrD 13 (72.2%) 6 (60.0%) 12 (92.3%) 4 (66.6%) 7 (87.5%) 0
vwb 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
Regulatory genes
agr
I 5 (27.7%) 2 (20.0%) 7 (53.8%) 5 (83.3%) 2 (25%) 0
II 1 (5.5%) 2 (20.0%) 3 (23.0%) 1 (16.6%) 3 (37.5%) 0
III 12 (66.6%) 6 (60%) 3 (23.0%) 0 3 (37.5%) 0
IV 0 0 0 0 0 0
sarA 18 (100%) 10 (100%) 13 (100%) 6 (100%) 8 (100%) 0
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For MSCRAMMs genes, clf A/B, ebpS, eno, fnbA, map, sdrC, and vwb genes were detected in
all isolates, regardless of their origin or ability to form biofilms. In biofilm-producing isolates
originating from sheep mastitis, the cna gene was not detected, while the cna gene was found in 50% of
biofilm-producing isolates from humans (5/10) and food (4/8). The fnbB gene was identified in all food
isolates and moderately detected in 40% (2/5) in sheep mastitis biofilm-producing isolates.
The results revealed that agrI, agrII, and agrIII types were detected in 7 (1 moderate and 6 weak
adherent), 6 (4 strong and 2 weak adherent), and 6 (4 strong and 2 moderate adherent) biofilm-producing
S. aureus isolates, respectively.
Sixty percent (3/5) of biofilm-producing isolates from sheep mastitis cases and 20% (2/10) of
isolates from humans belonged to agrIII. In biofilm-producing S. aureus isolated from humans, agrI was
predominantly detected in five isolates (50%), followed by agrII in 3 isolates (30%). In biofilm-producing
S. aureus isolated from food samples, agrII and agrIII were equally detected (37.5%), while agrI was
found in 2 (25%) isolates.
The cna, fnbB, and sasG genes were occasionally detected in S. aureus isolated from sheep mastitis
(21.4%, 17.9%, and 32.1%, respectively), but frequently among human isolates, in either slime producers
or non-slime producers.
The cna gene was detected in 8 (61.5%), 4 (50%), and 4 (22.2%) of slime-producing S. aureus
originating from humans, food, and sheep mastitis, respectively. The fnbB gene was found in 100%,
61.5%, and 16.7% of slime-producing S. aureus isolated from food isolates (8/8), humans (8/13), and
sheep mastitis (3/18), respectively.
The sdrD gene was detected in 42 isolated S. aureus in this study. The sdrD gene was found in 12
(92.3%), 7 (87.5%), and 18 (72.2%) of slime-producing S. aureus originating from humans, food, and
sheep mastitis, respectively. Noticeably, the sdrD gene was found more frequently in slime producers
than in non-slime producers (p > 0.05).
The results revealed that the agrI, agrII, and agrIII genes were detected in 14 (35.9%), 7 (17.9%),
and 18 (46.2%) slime-producing S. aureus, respectively.
Among the slime-producing isolates assigned to agrIII, 66.7% (12/18), 37.5% (3/8), and 23.1% (3/13)
were obtained from sheep mastitis, food, and humans, respectively. In slime-producing S. aureus
isolated from humans, agrI was detected in 7 isolates (53.8%) followed by agrII and agrIII in 3 isolates
(23.1%). In slime-producing S. aureus isolates from food samples, agrII and agrIII were equally often
detected (37.5%), while agrI was found in 25% of the isolates.
4. Discussion
Staphylococcus aureus is a zoonotic pathogen capable of causing a wide variety of syndromes
in animals and humans. Biofilm-producing S. aureus is considered as a major public and animal
health concern. The objectives of this study were to investigate the biofilm-forming ability of S.
aureus isolated from different sources and to analyze biofilm-associated and regulatory genes using
microarray analysis.
In this study, all isolates from food showed higher biofilm production than those from humans
(52.6%) and sheep mastitis cases (17.9%). This result was in concordance with the study of
Rodriguez-Lazaro et al. [38]. Most of S. aureus isolates from sheep mastitis did not form biofilms
(82.1%), which was in concordance with a previous report on S. aureus isolates from sheep milk [39]. In
the present study, 52.6% of human isolates were biofilm-producing S. aureus. Concordantly, it was
reported that isolates able to produce biofilm were more often found among clinical isolates from
humans than in commensal isolates [40].
The CRA assay showed that slime production occurred frequently (70.1%) and isolates from food
are more likely to be slime producers (100%) than isolates from humans (68.4%) or sheep mastitis
(64.3%) isolates. The present findings were in concordance with studies of Ammendolia et al. for
human clinical isolates (88.9%) [41] and Duran et al. for isolates from nasal samples (58.3%) [42].
Pathogens 2020, 9, 153 10 of 15
The cross-analysis of biofilm-formation and slime production ability using the results of TCP
and CRA assays revealed no perfect correlation in S. aureus isolated from humans (52.6% versus
68.4%) and sheep mastitis cases (17.9% versus 64.3%), but matched perfectly in food. This finding
corroborates the results of a previous study on S. aureus strains, in which isolates from bovine mastitis
were more frequently slime-producing (CRA assay) than biofilm-forming isolates on TCA (91.4%
versus 68.6%) [43].
Subsequent microarray analysis showed high genetic diversity among isolated S. aureus from
different sources in this study.
In this study, S. aureus isolates were genetically diverse (15 CCs). The ruminant leukocidin
genes lukF-P83 and lukM were found in 27 isolates (25 sheep, 1 human, and 1 food). The
Panton-Valentine-Leukocidin (PVL) gene, which is mostly associated with community-acquired
MRSA infections, was detected only in one MRSA isolated from a human.
Previous investigations showed that the intracellular adhesion (icaACD) gene products are
important in the ability of S. aureus biofilm formation [44,45]. The presented data of the DNA
microarray analysis revealed that all S. aureus isolates harbored icaACD genes regardless of their origin.
These results were in agreement with several findings made in human infections [46], human nasal
samples [47], sheep mastitis [48], and isolates from food matrices [6].
Here, not all icaACD gene-carrying isolates had the capacity to produce biofilms and/or slime.
It was reported that the correlation between ica carriage and biofilm-forming ability in S. aureus is
unpredictable [3], because the expression of biofilm-depending genes and adhesion on surfaces is a
complex process of gene regulation dependant on several factors as well as nutrients, pH value, and
surface characteristics [15,18,19,49].
In this study, presence of the bap gene was not found in any of the isolates. In general, the bap
gene, which promotes inert surfaces and intracellular adhesion, is rarely observed in S. aureus [39,50]
and its presence has only been reported in few S. aureus isolates from cases of bovine and sheep
mastitis [39,51,52].
On the other hand, few extracellular proteins as well as cell-bound MSCRAMMs are considered
essential for the pathogenicity of S. aureus. Indeed, genes like fnb (A and B), clf A, and cna that encode
MSCRAMMs are responsible for adhesion to host cells, and may participate in biofilm formation [53].
In S. aureus, fnbAB genes encode for fibronectin-binding proteins, which are functioning as adhesins
and invasins to modulate adherence and internalization, and it has also been reported to facilitate
biofilm assembly [53,54].
FnBPA and FnBPB proteins are involved in biofilm maturation but not in primary attachment.
They are generally involved in the ica-encoded polysaccharide intercellular adhesion (PIA) [54]. This
function was confirmed by a report in which a primary attached biofilm was damaged by fnbAB
mutation [53]. The findings of this study showed that fnbA and fnbB were detected in 100% and 41.8%
of all S. aureus isolates, respectively. In a previous study, fnbA and fnbB genes were detected in 77.8%
and 81% of MRSA isolates from patients, respectively [55]. Here, the fnbB gene was rarely detected
among non-biofilm-producing isolates but found in all biofilm-producing isolates from food matrices
and humans. These findings were in discordance with a previous reports where either the fnbB gene
was not detected in biofilm-producing isolates [6] or detected in a low level (29.0%) in MRSA isolated
from humans [50]. However, a previous study reported that fnbB occurred frequently (99.5%) in S.
aureus isolated from humans [46].
Clumping factors ClfA and ClfB encoded by the genes clf A and clf B are the most important
proteins for the binding of S. aureus to fibrinogen and fibrin [56]. In this study, all S. aureus harbored
clf AB genes, which is contradictory to reports on sheep mastitis isolates [7] and isolates from human
nasal and clinical samples [50].
Our findings showed that 57.1% of biofilm-producing isolates from food carried the cna gene,
while in previous studies, it was reported that 80% of the biofilm-forming isolates from food were
cna-positive [6] and 73% of the clinical isolates [55]. Contrary to our results, another study showed that
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only 17% of S. aureus isolated from sheep mastitis possessed the cna gene, suggesting that the cna gene
was detected only in some clonal complexes of S. aureus [57].
The sasG gene (surface protein of S. aureus) was shown to promote the formation of biofilms [58].
The present findings revealed that the sasG gene was frequently detected in the biofilm-producing S.
aureus independent from the MSCRAMMs genetic performance. Indeed, the product of sasG has the
ability to mask other binding components of S. aureus to microbial surface components (MSCRAMMs),
including clf B, and limits their promoting to form biofilms [56,59]. Furthermore, sasG promotes
strong adhesion affinity, even with masking clf B and independent of the ica-encoded PIA with its
masking properties. The sasG biofilm formation was clearly shown to be dependent on the level of
sasG expression [59].
In S. aureus, the accessory gene regulator (agr) and the staphylococcal accessory regulator (sarA)
are genetic loci that determine the regulation and control of the expression of several virulence
determinants [57]. Both sarA and agr play global regulatory roles in the limitation and/or propagation
of S. aureus biofilm formation [20,60].
The biofilm-producing S. aureus strains isolated from food in this study carried agrI, II, or III, while
other studies found that the majority (60%) of biofilm-producing S. aureus were the carriers of agrIII [6].
In S. aureus isolated from humans in this study, the agrI was more predominant in biofilm producers
followed by agrII, which disagreed with a previous study in Palestine that reported biofilm-producing
S. aureus isolated from humans mainly possessed agrI and agrIII [50]. It was reported that agr expression
can restrict biofilm formation allowing the colonization of a new surface by dispersion of the bacterium
from a previously formed biofilm [12,61].
The sarA gene is strongly related to the polysaccharide poly-N-acetylglucosamine (PNAG)-
dependent biofilm formation in S. aureus [60,62]. In this study, all isolates carried the sarA gene
independent of their ability to form biofilms. The detection of sarA is likely correlated to the detection
of icaACD loci, as demonstrated by previous findings [55,60,62] where isolates harboring icaADBC
genes were found to be positive for the sarA gene and isolates of the icaADBC-negative genotype did
not carry sarA.
The biofilm formation ability of S. aureus isolated from sheep mastitis cases was detected in
17.9% of isolated strains consolidated the fact that pathogenesis of udder infection critically depends
on adhesion of S. aureus to the mammary gland parenchyma. In the same tendency, the binding
and/or insertion ability of S. aureus to mammary gland epithelium was related to the production of
biofilms [13]. In addition, biofilm formation limits antimicrobial agents therapy of mastitis by reducing
the diffusion of antibiotics through the biofilm matrix [14,63].
In conclusion, S. aureus as known pathogenic bacteria can induce gene expression of biofilm that
has an important role in the pathogenesis of staphylococcal infections and causes bacterial attachment
and colonization on tissues or surfaces that may act as a substrate for microbial adhesion. This study
revealed the biofilm-forming ability of S. aureus isolated from human, animal, and food samples. It
represents an extensive analysis of several potential biofilm-associated-genes in S. aureus isolates. The
results of this study proved that MSSA isolates from food origin have significant capacity for forming
biofilms, which can play a key role for the successful dissemination of MSSA lineages via food.
Therefore, significant differences in gene carriage between biofilm-forming and
non-biofilm-forming isolates were not observed.
To the best of our knowledge, the current study is the first of its kind in Algeria to evaluate the
biofilm and slime-forming abilities among S. aureus recovered from different origins.
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